3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Myeloid, Acute
3
Hodgkin Disease
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Leukemia, Biphenotypic, Acute
2
Burkitt Lymphoma
2
Teratoma
1
Solid Tumors
1
Sarcoma
1
Rhabdomyosarcoma
1
Recurrence
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Multi-centric Castleman's Disease
1
Malignant mesenchymal tumor
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Lymphadenopathy
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid
1
Leukemia
1
Hematologic Neoplasms
1
HIV Infections
1
Glioma
1
Glioblastoma
1
Interventions
Paclitaxel
12
Carboplatin
12
Bevacizumab
11
liposomal doxorubicin
8
Specimen Handling
8
olaparib
7
Magnetic Resonance Spectroscopy
7
Topotecan
4
Gemcitabine
4
Biopsy
4
pembrolizumab
3
mirvetuximab soravtansine
3
Taxes
3
Doxorubicin
3
sarilumab
2
niraparib
2
cemiplimab
2
cediranib
2
Immunoglobulin G
2
Disulfides
2
1-dodecylpyridoxal
2
trastuzumab deruxtecan
1
tocilizumab
1
sotorasib
1
peposertib
1
pelcitoclax
1
palbociclib
1
nilotinib
1
neratinib
1
irinotecan sucrosofate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Fallopian Tube Neoplasms
×
Filgrastim
×
30 days
×
Clear all
No trials found.